Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Virology|January 25, 2008
Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesisShari N Gordon, Richard M Dunham, Jessica C Engram, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
The Journal of Clinical Investigation|January 17, 2013
Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaquesNichole R Klatt, Lauren A Canary, Xiaoyong Sun, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.
Mabs|January 13, 2010
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41Donna L Montgomery, Ying-Jie Wang, Renee Hrin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2014
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trialsEvguenia S Svarovskaia, Hadas Dvory-Sobol, Neil Parkin, et al.
Lancet (London, England)|January 16, 2010
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsJoseph J Eron, Benjamin Young, David A Cooper, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Pageof 21